The insurability of innovative pharmaceutical cancer technologies

Abstract The scientific literature, including several papers published in the IJHPR, has raised the issue of the spiraling cost of cancer treatment, including that of cancer drugs and other technologies such as gene and cell therapies. In this perspective, we review three criteria for insurability a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shuli Brammli Greenberg (Autor), Einat Dotan (Autor), Rachel Arazi (Autor)
Formato: Libro
Publicado: BMC, 2020-12-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible